EGFR and lung carcinoma: Furthermore, 6b emerged as the most promising anti-EGFR inhibitor with a great effect on gefitinib-resistant H1975 lung cancer cells, decreased oxidative stress and altered mitochondrial membrane potential leading to apoptosis and induced cell cycle arrest in A549 lung cancer cells at G phase.